FIELD: medicine.
SUBSTANCE: method provides phagocyte recovery from a cell mixture. The recovered cells are mixed with medium 199 in 18 bottles, and the cells are attached to glass at room temperature for 60 minutes. In 9 bottles, a culture medium containing medium 199, L-glutamine and mixed human serum heated for 30 min at 52°C is added to the cells in the preset amounts to produce cell samples. A culture medium of said composition containing 0.01% of zymosan particles is added to another 9 bottles with the cells to produce the cell samples. The prepared cell samples are divided into three portions. One one-third potion of zymosan and zymosan-free samples are frozen. The second portion of the zymosan and zymosan-free cell samples are cultivated at temperature 37°C for 4 to 6 h to be frozen, and the third portion of the zymosan and zymosan-free samples are cultivated at temperature 37°C for 18 to 24 h to be frozen respectively. All 18 bottles are exposed to simultaneous multiple freezing to -10°C and thawing at room temperature to complete recovery of intracellular lysozyme with determination of amount by a micromethod and calculation of synthesised lysozyme and a phagocyte activation value (PAV) by formula: PAV=Z Lsynth - Z-free Lsynth, mcg/ml, where Z Lsynth is a difference of lysozyme amount in the cultivated zymosan cells and lysozyme amount in the uncultivated zymosan cells, mcg/ml; Z-free Lsynth is a difference of lysozyme amount in the cultivated zymosan-free cells and lysozyme amount in the uncultivated zymosan-free cells, mcg/ml; the phagocyte activation value for long-term activation mechanism assessment is calculated by said formula by results of cell cultivation for 4 to 6 hours, and the phagocyte activation value for long-term activation mechanism assessment is calculated by said formula by results of cell cultivation for 18 to 24 hours.
EFFECT: invention allows more precise phagocyte activation assessment.
4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INCORPORATION OF BIOLOGICALLY ACTIVE MICRO- AND NANOPARTICLES IN NEUTROPHILS | 2016 |
|
RU2633502C2 |
EXPERIMENTAL METHOD OF TREATING LIVER CANCER BY INTRAPORTAL INTRODUCTION OF ZYMOZAN INCORPORATED INTO PHAGOCYTES | 2011 |
|
RU2485496C2 |
METHOD OF MEASURING STIMULATING EFFECT OF IMMUNOGLOBULINE PREPARATIONS FOR INTRAVENOUS INJECTION ONTO PROTECTIVE ACTIVITY OF PHAGOCITES | 2006 |
|
RU2318202C1 |
METHOD FOR ASSESSING PHAGOCYTIC ACTIVITY OF NEUTROPHILS | 2023 |
|
RU2824345C1 |
USE OF GRAPHENE OXIDE TO ACTIVATE PHAGOCYTIC FUNCTION OF MACROPHAGES | 2022 |
|
RU2809372C1 |
METHOD FOR ASSESSMENT OF FUNCTIONAL ABILITY OF PHAGOCYTES | 2011 |
|
RU2445626C1 |
COMPOUND STIMULATING DURING EXPERIMENT SYNTHESIS OF IMMUNOGLOBULINS | 1995 |
|
RU2108096C1 |
METHOD FOR DIAGNOSING CHRONIC HEPATITIS IN CHILDREN | 1997 |
|
RU2131125C1 |
METHOD OF EVALUATION OF HUMAN BLOOD MONOCYTE PHAGOCYTIC ACTIVITY | 1994 |
|
RU2089899C1 |
METHOD FOR DETERMINING THE ACTIVITY OF RECEPTORS OF HUMAN NEUTROPHILS | 0 |
|
SU1686372A1 |
Authors
Dates
2011-09-10—Published
2010-04-16—Filed